Gary H. Gibbons, M.D.


One of the long-term goals of our research is to utilize new genomic technologies to integrate the areas of physiologic genomics, functional genomics and human molecular genetics in the field of vascular biology and medicine. I have had a longstanding interest in elucidating the molecular mechanisms involved in vascular remodeling in health and disease. My laboratory is interested in discovering novel mediators of vascular disease that may constitute candidate disease susceptibility variants. We are actively involved in collaborative projects designed to study the functional significance of epigenetic and genomic variation and the potential role of genetic variation in promoting the susceptibility to cardiovascular disease in both clinical and community-based settings. One of the ultimate goals is to take a multi-level, multi-disciplinary approach to understanding and ameliorating racial/ethnic disparities in cardiovascular health.

Search Pew Scholars